Curis Lifesciences Limited (NSE:CURIS)

Curis Lifesciences Revenue

In the fiscal year ending March 31, 2026, Curis Lifesciences had annual revenue of 606.29M INR with 22.16% growth.

• Revenue: 606.29M
• Revenue Growth: +22.16%
• P/S Ratio: 1.49
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 905.46M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	606.29M	109.97M	22.16%
Mar 31, 2025	496.32M	140.77M	39.59%
Mar 31, 2024	355.56M	1.07M	0.30%
Mar 31, 2023	354.49M	117.04M	49.29%
Mar 31, 2022	237.45M	24.85M	11.69%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 20, 2026

Data Sources Report a data error